Top

Published in:

01-01-2011 | Original Contribution

Altered circadian rhythm of cardiac β3-adrenoceptor activity following myocardial infarction in the rat

Authors: Lan Zhou, Peng Zhang, Zhongwei Cheng, Wei Hao, Rui Wang, Quan Fang, Ji-Min Cao

Published in: Basic Research in Cardiology | Issue 1/2011

Abstract

Circadian rhythms influence the incidence of adverse cardiac events but the underlying mechanisms are not well defined. We sought to investigate the role of the β3-adrenoceptor (β3-AR) in cardiac circadian disorders and arrhythmia severity after myocardial infarction (MI). MI was created by ligating the left anterior descending coronary artery of the rat heart in situ. Circadian variations of the myocardial expressions of β3-AR and clock genes Bmal1 and Npas2 were examined by real time reverse transcription polymerase chain reaction, Western blot and immunohistochemistry. Electrocardiograms and myocardial contraction were recorded in vivo and/or ex vivo. Ventricular tachyarrhythmias were induced by isoprenaline. Normal rats showed circadian oscillations in both the myocardial transcriptional expression of β3-AR and the β3-AR-induced positive chronotropic and negative inotropic cardiac effects. However, these circadian rhythms were significantly blunted or even abolished in rats with either acute MI (within 24 h) or healed MI (14 days after coronary ligation). The nocturnal level of β3-AR protein was higher in MI rats than in normal rats. In contrast, the circadian oscillations of the transcripts of Bmal1 and Npas2 in the myocardium were significantly augmented in rats with either acute MI or healed MI. BRL37344, a preferential β3-AR selective agonist, reduced the occurrence of ventricular tachycardia (VT) and ventricular fibrillation (VF) in rats with either acute MI or healed MI. We conclude that circadian rhythms of myocardial β3-AR activities are disturbed after MI and β3-AR activation offers anti-arrhythmic protection.

Angelone T, Filice E, Quintieri AM, Imbrogno S, Recchia A, Pulerà E, Mannarino C, Pellegrino D, Cerra MC (2008) Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway. Acta Physiol (Oxf) 193:229–239CrossRef

Behrens S, Franz MR (2001) Circadian variation of arrhythmic events, electrophysiological properties, and the autonomic nervous system. Eur Heart J 22:2144–2146CrossRefPubMed

Bosch RF, Schneck AC, Kiehn J, Zhang W, Hambrock A, Eigenberger BW, Rüb N, Gogel J, Mewis C, Seipel L, Kühlkamp V (2002) Beta3-Adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes. Cardiovasc Res 56:393–403CrossRefPubMed

Dudley CA, Erbel-Sieler C, Estill SJ, Reick M, Franken P, Pitts S, McKnight SL (2003) Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice. Science 301:379–383CrossRefPubMed

Durgan DJ, Hotze MA, Tomlin TM, Egbejimi O, Graveleau C, Abel ED, Shaw CA, Bray MS, Hardin PE, Young ME (2005) The intrinsic circadian clock within the cardiomyocyte. Am J Physiol Heart Circ Physiol 289:H1530–H1541CrossRefPubMed

Durgan DJ, Young ME (2010) The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 106:647–658CrossRefPubMed

Fabritz L, Damke D, Emmerich M, Kaufmann S, Theis K, Blana A, Fortmuller L, Laakmann S, Hermann S, Aleynichenko E, Steinfurt J, Volkery D, Riemann B, Kirchhefer U, Franz MR, Breithardt G, Carmeliet E, Schafers M, Maier SK, Carmeliet P, Kirchhof P (2010) Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Cardiovasc Res 87:60–72CrossRefPubMed

Gauthier C, Langin D, Balligand JL (2000) Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21:426–431CrossRefPubMed

Gauthier C, Moniotte S, Langin D, Balligand JL (2000) The negative inotropic action of catecholamines: role of beta3-adrenoceptors. Can J Physiol Pharmacol 78:681–690CrossRefPubMed

10.

Guzzetti S, Spyrou N, Rosen SD, Mezzetti S, Martinoli E, Foale RA, Camici PG (2002) Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction. Basic Res Cardiol 97:97–104CrossRefPubMed

11.

Harding SE (1997) Lack of evidence for β3-adrenoceptor modulation of contractile function in human ventricular myocytes (abstract). Circulation 96(Suppl 1):I–I53

12.

Hutchinson DS, Bengtsson T, Evans BA, Summers RJ (2002) Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br J Pharmacol 135:1903–1914CrossRefPubMed

13.

Kies P, Wichter T, Schafers M, Paul M, Schafers KP, Eckardt L, Stegger L, Schulze-Bahr E, Rimoldi O, Breithardt G, Schober O, Camici PG (2004) Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation 110:3017–3022CrossRefPubMed

14.

Kohout TA, Takaoka H, McDonald PH, Perry SJ, Mao L, Lefkowitz RJ, Rockman HA (2001) Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104:2485–2491CrossRefPubMed

15.

Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA (2005) Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 294:1526–1533CrossRefPubMed

16.

Leblais V, Demolombe S, Vallette G, Langin D, Baró I, Escande D, Gauthier C (1999) Beta3-adrenoceptor controls the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. J Biol Chem 274:6107–6113CrossRefPubMed

17.

Lohse MJ, Engelhardt S, Eschenhagen T (2003) What is the role of beta-adrenergic signaling in heart failure? Circ Res 93:896–906CrossRefPubMed

18.

Martino T, Arab S, Straume M, Belsham DD, Tata N, Cai F, Liu P, Trivieri M, Ralph M, Sole MJ (2004) Day/night rhythms in gene expression of the normal murine heart. J Mol Med 82:256–264CrossRefPubMed

19.

McNamara P, Seo SB, Rudic RD, Sehgal A, Chakravarti D, FitsGerald GA (2001) Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 105:877–889CrossRefPubMed

20.

Mohri T, Emoto N, Nonaka H, Fukuya H, Yagita K, Okamura H, Yokoyama M (2003) Alterations of circadian expressions of clock genes in dahl salt-sensitive rats fed a high-salt diet. Hypertension 42:189–194CrossRefPubMed

21.

Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL (2001) Upregulation of β3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103:1649–1655PubMed

22.

Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T (2002) Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension 40:827–833CrossRefPubMed

23.

Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J (2010) Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327:1653–1657CrossRefPubMed

24.

Oikonomidis DL, Tsalikakis DG, Baltogiannis GG, Tzallas AT, Xourgia X, Agelaki MG, Megalou AJ, Fotopoulos A, Papalois A, Kyriakides ZS, Kolettis TM (2010) Endothelin-B receptors and ventricular arrhythmogenesis in the rat model of acute myocardial infarction. Basic Res Cardiol 105:235–245CrossRefPubMed

25.

Rasmussen HH, Figtree GA, Krum H, Bundgaard H (2009) The use of beta3-adrenergic receptor agonists in the treatment of heart failure. Curr Opin Investig Drugs 10:955–962PubMed

26.

Reppert SM, Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647–676CrossRefPubMed

27.

Rozec B, Gauthier C (2006) Beta3-adrenoceptors in cardiovascular system: putative roles in human pathologies. Pharmacol Ther 111:652–673CrossRefPubMed

28.

Sanbe A, Takeo S (1995) Diminished responsiveness to cardiac beta 1-adrenoceptor agonists in rats with chronic heart failure following myocardial infarction. Biol Pharm Bull 18:1362–1366PubMed

29.

Sato M, Hutchinson DS, Evans BA, Summers RJ (2007) Functional domains of the mouse beta(3)-adrenoceptor associated with differential G-protein coupling. Biochem Soc Trans 35(Pt 5):1035–1037PubMed

30.

Shaw JA, Chin-Dusting JP, Kingwell BA, Dart AM (2001) Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 103:806–812PubMed

31.

Skeberdis VA, Gendviliene V, Zablockaite D, Treinys R, Macianskiene R, Bogdelis A, Jurevicius J, Fischmeister R (2008) Beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca²⁺ current. J Clin Invest 118:3219–3227PubMed

32.

Spyrou N, Rosen SD, Fath-Ordoubadi F, Jagathesan R, Foale R, Kooner JS, Camici PG (2002) Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol 40:1216–1224CrossRefPubMed

33.

Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ (2002) Extensive and divergent circadian gene expression in liver and heart. Nature 417:78–83CrossRefPubMed

34.

Tavernier G, Toumaniantz G, Erfanian M, Heymann MF, Laurent K, Langin D, Gauthier C (2003) Beta3-adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Cardiovasc Res 59:288–296CrossRefPubMed

35.

Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87:454–463PubMed

36.

Ursino MG, Vasina V, Raschi E, Crema F, De Ponti F (2009) The beta3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res 59:221–234CrossRefPubMed

37.

Waldeyer C, Fabritz L, Fortmueller L, Gerss J, Damke D, Blana A, Laakmann S, Kreienkamp N, Volkery D, Breithardt G, Kirchhof P (2009) Regional, age-dependent, and genotype-dependent differences in ventricular action potential duration and activation time in 410 Langendorff-perfused mouse hearts. Basic Res Cardiol 104:523–533CrossRefPubMed

38.

Xu XB, Cao JM, Pang JJ, Xu RK, Ni C, Zhu WL, Asotra K, Chen MC, Chen C (2003) The positive inotropic and calcium-mobilizing effects of growth hormone-releasing peptides on rat heart. Endocrinology 144:5050–5057CrossRefPubMed

39.

Young ME (2006) The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 290:H1–H16CrossRefPubMed

40.

Young ME, Razeghi P, Cedars AM, Guthrie PH, Taegtmeyer H (2001) Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 89:1199–1208CrossRefPubMed

41.

Young ME, Razeghi P, Taegtmeyer H (2001) Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 88:1142–1150CrossRefPubMed

42.

Young ME, Wilson CR, Razeghi P, Guthrie PH, Taegtmeyer H (2002) Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol 34:223–231CrossRefPubMed

43.

Zhang J, Dong X, Fujimoto Y, Okamura H (2004) Molecular signals of mammalian circadian clock. Kobe J Med Sci 50:101–109PubMed

44.

Zhou S, Paz O, Cao JM, Asotra K, Chai NN, Wang C, Chen LS, Fishbein MC, Sharifi B, Chen PS (2005) Differential β-adrenoceptor expression induced by nerve growth factor infusion into the canine right and left stellate ganglia. Heart Rhythm 2:1347–1355CrossRefPubMed

45.

Zhou S, Tan AY, Paz O, Ogawa M, Chou CC, Hayashi H, Nihei M, Fishbein MC, Chen LS, Lin SF, Chen PS (2008) Antiarrhythmic effects of beta3-adrenergic receptor stimulation in a canine model of ventricular tachycardia. Heart Rhythm 5:289–297CrossRefPubMed

Title: Altered circadian rhythm of cardiac β3-adrenoceptor activity following myocardial infarction in the rat
Authors: Lan Zhou
Peng Zhang
Zhongwei Cheng
Wei Hao
Rui Wang
Quan Fang
Ji-Min Cao
Publication date: 01-01-2011
Publisher: Springer-Verlag
Published in: Basic Research in Cardiology / Issue 1/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-010-0110-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Altered circadian rhythm of cardiac β3-adrenoceptor activity following myocardial infarction in the rat

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes

Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability

Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation

Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability

MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction

Expression of mitochondrial fusion–fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page